SitemapKlarity storyJoin usMedicationServiceAbout us
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
based on 0 reviews
fsaAccept major insurances and cash-pay
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
based on 0 reviews
fsaAccept major insurances and cash-pay
Back

Published: Jun 26, 2026

Share

GLP-1 Telehealth: What PMHNPs Need to Know in Texas

Share

Written by Klarity Editorial Team

Published: Jun 26, 2026

GLP-1 Telehealth: What PMHNPs Need to Know in Texas
Table of contents
Share

You’ve probably noticed it in your patient panels: the quiet question about ‘that weight-loss shot everyone’s talking about,’ or the frustration from someone who’s gained 40 pounds on their antipsychotic. Maybe you’ve had a colleague mention they’re now prescribing semaglutide, or you’ve seen ads for telehealth weight-loss platforms offering $300+ per consult.

The numbers are real: by late 2025, an estimated 20 million Americans were actively taking GLP-1 medications like Ozempic or Wegovy — a 600% increase in weight-loss usage over just six years. And here’s the interesting part for psychiatrists: nearly half of psychiatrists surveyed in major academic departments reported they’re already prescribing or recommending these medications, often to address medication-induced weight gain or co-morbid obesity.

This isn’t some random side hustle. It’s a legitimate clinical opportunity that plays directly to psychiatry’s strengths: understanding behavior change, managing chronic treatments, and addressing the psychological aspects of health that most weight-loss clinics ignore entirely.

But here’s the reality check: scaling a GLP-1 practice without drowning in admin work, patient volume, or compliance headaches requires intentional strategy. Let’s talk about how to actually do this — the patient acquisition, the workflows, the economics, and most importantly, how to avoid burning out while building something sustainable.

Why Psychiatrists Are Uniquely Positioned for GLP-1 Care

The Patient Overlap You Already Have

Start by looking at your current caseload. How many patients are on medications known for weight gain? Antipsychotics, mood stabilizers, mirtazapine, certain SSRIs — the list is long, and the frustration is real. These patients aren’t asking for vanity prescriptions; they’re dealing with a iatrogenic problem that affects their self-esteem, physical health, and often their willingness to stay on psychiatric medications.

By offering GLP-1 treatment, you’re not pivoting to a completely different specialty — you’re addressing a legitimate medical complication of the care you’re already providing. This integrated approach resonates with patients who feel like their mental and physical health are finally being treated as connected, not siloed.

Beyond medication side effects, there’s significant overlap between psychiatric conditions and obesity. Binge eating disorder, emotional eating tied to depression or anxiety, the metabolic effects of chronic stress — these are all in psychiatry’s wheelhouse. Unlike a nurse practitioner working for a generic telehealth weight-loss mill, you bring actual expertise in the behavioral and mental health components that determine whether patients succeed long-term.

What the Market Actually Looks Like

The demand is overwhelming the supply. With roughly 75% of Americans overweight or obese and only a few thousand board-certified obesity medicine specialists nationwide, there’s a massive access gap. Tens of thousands of new patients start GLP-1 treatments every week, and many can’t access specialized obesity clinics or don’t want to wait months for an appointment.

This creates an unusual opportunity: relatively little competition, especially in telehealth. Yes, there are startups and cash-pay clinics everywhere now, but most are staffed by providers with no mental health training. When patients search for ‘psychiatrist GLP-1’ or ‘weight loss medication for depression patients,’ there’s often nobody ranking for those terms in their area.

The cash-pay economics make this even more attractive. While insurance coverage for GLP-1s remains limited (only 13 state Medicaid programs covered them for weight loss as of late 2024), patients are often willing to pay out-of-pocket for these ‘life-changing’ medications. Monthly consultation fees typically range from $99-$299, and if you’re operating through a platform or with good conversion, you can fill your practice faster than traditional psychiatric patient acquisition — which brings us to the business model question.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Real Economics: How to Actually Get GLP-1 Patients

Let’s be honest about what patient acquisition actually costs and how the economics work, because this is where a lot of providers get misled by overly optimistic projections.

DIY Marketing: The Hidden Costs

If you decide to market a GLP-1 service independently — through your own website, Google Ads, or directory listings — understand the real numbers. Acquiring a qualified psychiatric patient through DIY channels typically costs $200-500+ per patient when you factor in everything:

  • SEO takes 6-12 months of consistent content investment before generating meaningful patient flow. You’ll need an agency or consultant ($1,500-$3,000/month), plus your own time creating content.
  • Google Ads for mental health keywords run $15-40+ per click, and most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+ after accounting for testing, optimization, and no-shows from cold leads.
  • Directory listings like Psychology Today or Zocdoc charge monthly fees AND put you in competition with hundreds of other providers on the same page. Zocdoc charges $35-100+ per booking plus monthly subscription fees.

The bottom line: most solo providers don’t have the expertise, patience, or $3,000-5,000/month budget to make DIY marketing work efficiently. It can eventually be cost-effective if you stick with it long enough and know what you’re doing — but that’s a big ‘if.’

The Platform Economics Alternative

This is where platforms like Klarity Health change the math entirely. Instead of gambling thousands on marketing channels with uncertain results, you pay only when a qualified patient actually books with you — a standard listing fee per new patient lead, similar to how Zocdoc works.

Here’s why this model makes economic sense for most providers, especially those starting out or scaling:

  • No upfront marketing spend or monthly subscription fees — you’re not paying $3,000/month hoping patients show up
  • Pre-qualified patients already matched to your specialty and availability (no wasted time on tire-kickers or wrong-fit referrals)
  • No separate platform costs — telehealth infrastructure is built-in
  • You control your schedule — only accept patients when you have capacity
  • Both insurance and cash-pay patient flow depending on your preference

Think about it this way: if you spend $5,000 on marketing over three months and acquire 10 patients, that’s $500 per patient — and you paid it all upfront with no guarantee of results. With a pay-per-appointment model, you pay that same amount (or often less) but only when you actually see the patient. That’s guaranteed ROI versus gambling.

The key is treating this as a patient acquisition cost, not an expense. If that new GLP-1 patient generates $200-300 per month in consultation revenue and stays for an average of 12 months, the lifetime value is $2,400-3,600. Paying a one-time acquisition fee to access that patient makes perfect business sense.

Setting Up Your GLP-1 Practice: Compliance and Clinical Workflow

State Licensure and Scope of Practice

The regulatory landscape for GLP-1 prescribing via telehealth is straightforward in one sense and complex in another. The good news: GLP-1 medications are not controlled substances, which means the Ryan Haight Act’s in-person exam requirement doesn’t apply. You can legally prescribe semaglutide or tirzepatide to patients via telemedicine without ever meeting them face-to-face, as long as you meet standard-of-care requirements.

The complexity comes from state-specific rules:

For Psychiatrists (MD/DO): You simply need a medical license in the patient’s state. If you’re in California treating California patients, you need a CA license. Some states (like Florida) offer special out-of-state telehealth registrations for physicians, which can expand your reach without full licensure. Texas, Illinois, and Pennsylvania are members of the Interstate Medical Licensure Compact (IMLC), which can expedite multi-state licensing if you want to practice across state lines.

For PMHNPs: This gets more complicated because nurse practitioner scope varies wildly by state:

  • California: NPs must work under physician supervision unless they achieve new ‘104 NP’ independent status (available starting 2026 for those who completed 3 years as supervised ‘103 NPs’)
  • Texas & Pennsylvania: Strict physician collaboration required — no independent NP practice for any specialty
  • New York & Illinois: Experienced NPs can achieve full practice authority (after 3,600 hours in NY, or 4,000 hours plus additional education in IL)
  • Florida: Only primary care NPs can practice independently; psychiatric NPs still need physician oversight

If you’re an NP in a restricted state, you’ll need to either partner with a supervising physician or work through a platform that provides that supervision structure.

The Standard of Care for Telehealth GLP-1 Prescribing

Regardless of state, you need to conduct a proper clinical evaluation. This means:

  1. Comprehensive intake: Medical history, weight history, current medications, contraindications (history of medullary thyroid carcinoma, pancreatitis, multiple endocrine neoplasia), mental health screening
  2. Baseline measurements: BMI, weight, blood pressure
  3. Appropriate lab work: A1c, fasting glucose, liver enzymes, TSH if indicated
  4. Clear informed consent: Especially for off-label use (like prescribing Ozempic for obesity when Wegovy is the FDA-approved brand)
  5. Documentation of medical necessity: Why this patient qualifies for treatment (BMI ≥30, or ≥27 with comorbidities)

Create standardized intake forms and checklists to ensure consistency. Many telehealth practices use an ‘Obesity Intake Panel’ order set that can be clicked with one button — this saves time and ensures nothing gets missed.

One often-overlooked aspect: monitoring for psychiatric side effects. There were reports in 2023 about possible suicidal ideation linked to GLP-1s, though by 2026 the FDA reviewed data and found no clear causal link. Still, as a psychiatrist, you should routinely ask about mood changes during follow-ups — this is a value-add that distinguishes you from generic weight-loss providers.

Scaling Without Burning Out: The Workflow That Actually Works

Here’s where most providers fail: they add GLP-1 patients to their existing psychiatric practice without redesigning their workflow, and within three months they’re drowning in follow-up appointments and lifestyle counseling questions.

The Three-Phase System

Phase 1: Intensive Initiation (Month 1-3)New GLP-1 patients need more frequent touchpoints early on:

  • Initial comprehensive evaluation (45-60 min)
  • Follow-up at 2 weeks (check tolerance, side effects)
  • Monthly follow-ups for dose titration
  • Baseline education on diet, exercise, injection technique

Phase 2: Stable Maintenance (Month 4-12)Once patients are on a stable dose and losing weight predictably:

  • Follow-ups every 2-3 months (15-20 min visits)
  • Asynchronous check-ins via patient portal
  • Remote weight monitoring (patients report weekly weights through app)

Phase 3: Long-term Management (12+ months)Patients at goal weight or on maintenance dose:

  • Quarterly check-ins
  • Focus shifts to lifestyle maintenance and preventing regain

The key insight: these phases require different levels of provider involvement. You can’t sustain doing 45-minute diet counseling sessions with every patient every month. That’s where delegation comes in.

Delegation Strategy

Build a team structure that takes non-prescribing work off your plate:

  • Medical Assistant or RN: Gathers interim data (weights, BP, symptom questionnaires) before visits; handles routine patient questions via portal; manages prescription refills for stable patients
  • Health Coach or Dietitian: Conducts lifestyle counseling, either in group sessions or individual visits; runs weekly support groups for patients starting out; provides cooking tips, exercise guidance, accountability
  • Automated systems: Patient portal with FAQs; automated appointment reminders; template documentation for common visit types

For example: Instead of spending 20 minutes every visit discussing meal planning with each patient, your dietitian runs a monthly group telehealth session covering common topics (managing nausea, protein targets, eating out). Patients get better support, and you’ve just saved yourself 10+ hours per month.

Technology That Actually Saves Time

Invest in tools that reduce manual work:

  • Integrated telehealth EHR with video visits, e-prescribing, and messaging in one platform
  • Remote patient monitoring: Connected scales or simple app-based weight tracking — you see a dashboard of all patient trends at a glance
  • Template documentation: Build smart phrases for common scenarios (‘Patient tolerating dose well, nausea improving, down 8 lbs this month, advancing to 1.0mg weekly’)
  • Asynchronous check-ins: For stable patients, use secure messaging for brief updates instead of scheduling 15-minute video visits

One psychiatrist I know cut her average GLP-1 follow-up visit from 25 minutes to 12 minutes just by implementing pre-visit questionnaires and having her MA document the basics before she joined the call. That freed up 6-8 appointment slots per week.

Preventing Burnout: The Non-Negotiables

The irony of scaling a successful practice is that success itself can destroy you if you’re not careful. Here’s what actually matters:

Cap Your Volume Intentionally

Don’t let patient demand dictate your schedule. Decide in advance: ‘I’ll see 10 new GLP-1 consults per week, with 15 follow-ups.’ When you hit that limit, new patients go on a waitlist or you raise your prices. This prevents the endless treadmill of ‘just one more patient.’

Maintain Schedule Control

Research shows that greater schedule control and virtual practice options significantly reduce provider burnout. Telehealth gives you flexibility — use it. Block out admin time, lunch breaks, and early Friday afternoons. Set specific hours for patient communication (e.g., ‘I respond to messages between 12-2pm’) and use delayed delivery or an answering service for after-hours.

Mix Your Patient Types

If you’re doing both psychiatric and weight-management work, schedule variety into your day. Alternate between complex psychiatric cases and straightforward GLP-1 follow-ups. Many providers find this mix more engaging than pure specialty work — it keeps your skills sharp and prevents monotony.

Build in Support Structures

Join peer communities (obesity medicine interest groups, telehealth clinician forums) where you can discuss challenges and learn from others’ workflows. Consider formal obesity medicine CME or certification — not just for credentials, but because the education reduces uncertainty-driven stress.

Monitor Your Own Metrics

Track your own well-being as closely as patient outcomes. Are you working evenings regularly? Feeling emotionally exhausted? Dreading certain types of appointments? These are early warning signs. When they appear, adjust: hire more support staff, reduce new patient intake temporarily, or delegate additional tasks.

Cash-Pay vs Insurance: Making the Business Model Decision

Most GLP-1 telehealth practices favor cash-pay models for good reason: insurance coverage for obesity medications remains limited, and the reimbursement headaches aren’t worth it for many providers.

The Cash-Pay Case

Pros:

  • Simpler operations — no prior authorizations, no claims denials, no fighting with insurance
  • Direct revenue — patients pay upfront for consultations; you set your own rates
  • Faster practice growth — no need to credential with multiple insurers
  • Patient self-selection — people willing to pay cash are often more motivated and committed

Typical cash-pay structure:

  • Initial consultation: $199-$299
  • Monthly follow-ups: $99-$149
  • Some practices bundle into subscription packages ($299/month includes consults + medication through compounding pharmacy)

The challenge: You’re limiting your market to patients who can afford out-of-pocket costs, which excludes many who might benefit most.

The Insurance Case

Pros:

  • Wider patient access — especially important if you care about health equity
  • Larger potential market — particularly if more states expand Medicaid coverage (13 states covered GLP-1s for obesity as of 2024, including California and Pennsylvania)
  • Legitimacy — some patients prefer insurance-covered care and view cash-pay as less ‘real’

Cons:

  • Prior authorization battles — expect to spend time documenting medical necessity, BMI requirements, failed lifestyle interventions
  • Lower reimbursement — insurance pays less than cash rates
  • Billing complexity — you’ll need staff who understand obesity medicine billing codes

The Hybrid Approach

Many smart providers split the difference:

  • Charge cash for the comprehensive initial evaluation (which involves extensive education and counseling that insurance underpays)
  • Bill insurance for follow-up visits using standard E/M codes or Medicare’s obesity counseling code (G0447)
  • Help patients navigate insurance coverage for the medications themselves (some have good pharmacy benefits even if medical coverage is limited)

Be transparent with patients upfront about costs. Calculate their all-in monthly expense: consultation fees + medication costs (brand-name Wegovy is $1,300+ without coverage; compounded semaglutide runs $200-400). This prevents sticker shock and builds trust.

State-Specific Considerations Worth Knowing

Each state has quirks that affect how you operate:

California: Requires patient consent for telehealth (document it). Medi-Cal started covering GLP-1s for obesity in 2024, which may increase insured patient demand. Large, diverse market with high interest in metro areas but also underserved rural populations. NPs gain independence starting 2026 if they meet the AB 890 requirements.

Texas: Strict NP supervision requirements (collaborative agreement mandatory). IMLC member for physicians, which eases multi-state licensing. High obesity rate (~35%) and many rural areas = strong demand but fewer autonomous NP options. Telemedicine explicitly allowed without in-person visit requirement.

Florida: Out-of-state physicians can get telehealth registration (great for multi-state practices). NPs need physician oversight unless they’re primary care specialists. Large retirement population interested in health improvement, but limited Medicaid coverage means mostly cash-pay patients.

New York: Experienced NPs (3,600+ hours) can practice independently, expanding the provider pool. Huge population but competitive market in NYC. Upstate and rural areas face shortages. Good opportunity to partner with hospital systems addressing antipsychotic-induced weight gain.

Pennsylvania: NPs require physician collaborative agreements (no independent practice yet). Joined IMLC and Nurse Licensure Compact, easing some multi-state practice. Mix of urban and rural patients; Medicaid started covering GLP-1s in 2024.

Illinois: NPs can achieve Full Practice Authority after 4,000 hours + additional education. IMLC member for physicians. Strong telehealth parity law for insurance coverage. Medicaid covers GLP-1s for obesity. Academic centers in Chicago leave community practice gaps elsewhere.

The Bottom Line: Is This Worth Your Time?

Here’s the honest assessment: Adding GLP-1 services to your psychiatric practice can be financially rewarding (patient demand is real, acquisition costs are manageable through the right channels, and cash-pay economics work) and clinically meaningful (you’re addressing a genuine health problem for patients who often have limited options).

But it only works if you approach it strategically:

  1. Start small — dedicate a few half-days per week initially, test your workflows, learn the clinical management
  2. Invest in systems — templates, staff support, technology that saves time
  3. Choose your acquisition channel wisely — platforms that provide pre-qualified patients beat DIY marketing for most providers
  4. Protect your capacity — cap volume, maintain boundaries, monitor your own well-being
  5. Deliver real value — integrate mental health expertise, don’t just be another prescription mill

The providers who succeed with this are the ones who see it as an extension of psychiatric care, not a completely separate business. They’re treating the whole patient — mental health, metabolic health, behavior change — and leveraging psychiatry’s unique strengths in an area where demand far exceeds supply.

If you’re interested in exploring how telehealth platforms can connect you with qualified GLP-1 patients without the marketing headaches, Klarity Health’s provider network offers a pay-per-appointment model that eliminates upfront risk and provides the infrastructure to scale sustainably.


Frequently Asked Questions

Can psychiatrists legally prescribe GLP-1 medications like Ozempic or Wegovy?

Yes. Psychiatrists (MD/DO) have full prescriptive authority for GLP-1 medications in all states where they hold a medical license. These medications are not controlled substances, so there are no additional DEA requirements beyond your standard prescribing privileges. Psychiatric NPs can also prescribe them in most states, though scope-of-practice rules vary (some states require physician collaboration agreements).

Do I need to see patients in person before prescribing GLP-1 medications via telehealth?

No. Because GLP-1 medications are not controlled substances, the Ryan Haight Act’s in-person examination requirement doesn’t apply. You can establish a valid patient relationship and prescribe these medications entirely through telemedicine, as long as you conduct an appropriate clinical evaluation via video (or audio where state law permits) and meet the standard of care for your state. Most states explicitly allow this for non-controlled medications.

How much does it actually cost to acquire a new GLP-1 patient?

The real all-in cost for DIY patient acquisition typically runs $200-500+ per patient when you account for agency fees, ad spend, staff time qualifying leads, and no-show rates. SEO takes 6-12 months before generating meaningful patient flow, and Google Ads for weight-loss keywords cost $15-40+ per click with conversion rates that mean you’re paying $200-400+ per booked patient. Platform models like Klarity charge a standard listing fee per new patient lead, which eliminates upfront spend and provides pre-qualified patients — often more cost-effective than DIY marketing.

What’s the typical revenue potential from a GLP-1 patient?

In cash-pay models, initial consultations typically run $199-$299, with monthly follow-ups at $99-$149. Average patient retention is 8-12 months, making lifetime value $1,200-$2,400+ per patient in consultation fees alone. Some practices charge subscription fees ($299/month including consultations and compounded medication), which can generate $3,000-4,000+ per patient annually. Insurance-based models generate lower per-visit revenue but potentially higher volume through broader access.

How do I manage patient load without burning out?

Successful scaling requires three elements: (1) Delegation — use MAs/RNs for data gathering, health coaches for lifestyle counseling, and group sessions for common education topics; (2) Technology — templated documentation, remote patient monitoring, and asynchronous check-ins for stable patients; (3) Boundaries — cap new patient intake, set specific communication hours, and schedule admin time. Research shows that schedule control and flexible telehealth practice significantly reduce burnout compared to traditional high-volume models.

Should I offer GLP-1 services on a cash-pay or insurance basis?

Most telehealth GLP-1 practices favor cash-pay because: insurance coverage for obesity medications remains limited (only 13 state Medicaid programs covered them as of 2024), prior authorization burdens are substantial, and patients often pay out-of-pocket for medications anyway. However, a hybrid approach works well — charge cash for comprehensive initial evaluations, bill insurance for follow-up visits where coverage exists, and help patients navigate pharmacy benefits. The key is transparency about total monthly costs (consultations + medications) upfront.

What are the most common compliance mistakes providers make?

The top three: (1) Inadequate documentation of medical necessity (failing to document BMI, comorbidities, previous weight-loss attempts); (2) Not obtaining proper informed consent for off-label use (like prescribing Ozempic for obesity rather than diabetes); (3) Using unvetted compounding pharmacies that may not meet FDA quality standards. Also watch for state-specific requirements like California’s mandate for telehealth consent documentation.

How do I handle psychiatric side effects like mood changes on GLP-1s?

This is where psychiatrists have a clear advantage. While the FDA found no causal link between GLP-1s and suicidal ideation after reviewing data through 2026, you should routinely screen for mood changes at every follow-up. Use standardized questions: ‘Have you noticed any changes in your mood, anxiety, or sleep since starting/increasing the medication?’ Document responses and adjust care accordingly. Your mental health expertise is a differentiator — patients value having a prescriber who understands the psychological aspects of weight loss.

Can I prescribe to patients in multiple states?

Yes, but you need a medical license in each state where your patients are located. Some states (Florida) offer special out-of-state telehealth registrations for physicians. The Interstate Medical Licensure Compact (IMLC) — which includes Texas, Illinois, Pennsylvania, and others — provides expedited licensure processes for physicians wanting to practice in multiple member states. NPs face additional complexity with varying scope-of-practice rules and collaborative agreement requirements by state.

What do I tell patients about medication costs and insurance coverage?

Be upfront and realistic. Brand-name Wegovy typically costs $1,300+ per month without insurance coverage. Compounded semaglutide from quality pharmacies runs $200-400/month. While most insurance covers GLP-1s for diabetes, coverage for obesity is limited — patients should check with their specific plan. Help them understand the total monthly investment (consultation fees + medication costs) before starting treatment. This transparency builds trust and reduces dropout from sticker shock later.


References

  1. Axios. ‘Just how many Americans are taking GLP-1s now.’ May 27, 2025. Available at: https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing

  2. ConfectioneryNews. ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry.’ October 20, 2025. Available at: https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry

  3. Time Magazine. ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny.’ August 22, 2025. Available at: https://time.com/7311517/cost-weight-loss-drugs-skinny

  4. Axios. ‘America’s doctors need more obesity medicine training.’ May 28, 2024. Available at: https://www.axios.com/2024/05/28/us-doctors-obesity-health-care-training

  5. Axios. ‘States slow to cover GLP-1s for weight loss.’ November 5, 2024. Available at: https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss

Source:

Get expert care from top-rated providers

Find the right provider for your needs — select your state to find expert care near you.

Related posts

logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402

Join our mailing list for exclusive healthcare updates and tips.

Stay connected to receive the latest about special offers and health tips. By subscribing, you agree to our Terms & Conditions and Privacy Policy.
logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402
If you’re having an emergency or in emotional distress, here are some resources for immediate help: Emergency: Call 911. National Suicide Prevention Lifeline: call or text 988. Crisis Text Line: Text HOME to 741741.
HIPAA
© 2026 Klarity Health, Inc. All rights reserved.